期刊文献+

高血压患者靶器官评估的重要性 被引量:3

Importance of target organ damage assessment in hypertensive patients
下载PDF
导出
摘要 高血压即使没有症状,也往往合并有多种危险因素和靶器官损伤。而靶器官损伤越多,其心脑血管事件的风险越大。高血压患者的治疗方案取决于其同时伴随的危险因素和靶器官损伤的部位和数量。因此在诊断高血压的同时应调查其危险因素及做必要的辅助检查,评估其靶器官的功能状态,使患者得到合理的治疗,及早预防并发症的发生。 Objective Hypertension,even without symptoms,is often associated with multiple risk factors and target organ damage.The more target organ damage,the more risk of cardiovascular and cerebrovascular events.The treatment of hypertension patients depends on the risk factors,the location and quantity of target organ damage.Therefore,in the diagnosis of hypertension,risk factors should be in mind at the same time and necessary auxiliary examination,assessment of the functional status of its target organs should be pevformed,so that patients can get reasonable treatment,early prevention of complications.
作者 赵海鹰
出处 《临床荟萃》 CAS 2015年第11期1206-1210,共5页 Clinical Focus
关键词 高血压 靶器官损伤 评估 hypertension target organ damage assessment
  • 相关文献

参考文献22

  • 1《中国高血压基层管理指南》(2014年修订版)[J].临床荟萃,2015,30(7):725-744. 被引量:50
  • 2Triantafyllou A, Anyfanti P, Zabulis X, et al. Accumulation of microvascular target organ damage in newly diagnosed hypertensive patients[J]. J Am Soc Hypertens, 2014, 8(8) 542-549.
  • 3李岩,赵冬,刘静,李翠芬,果伟,陈赤红,郝蓬,孙佳艺,秦兰萍,王薇.北京地区25~64岁人群高血压左心室肥厚与心血管事件和死亡的关系[J].中华心血管病杂志,2008,36(11):1037-1042. 被引量:22
  • 4孙宁玲,王鸿懿,朱鼎良,廖玉华,林曙光,陈晓平.白蛋白尿与高血压患者血压水平的关系[J].中华肾脏病杂志,2010,26(10):762-765. 被引量:26
  • 5樊晓寒,惠汝太.高血压肾脏损害类型和机制研究进展[J].临床内科杂志,2008,25(10):716-718. 被引量:7
  • 6Harbaoui B, Courand PY, Defforges A, et al. Cumulative effects of several target organ damages in risk assessment in hypertension[J]. Am J Hypertens, 2015,Jun 25Epub ahead of print].
  • 7Vernooij JW, van der Graaf Y, Nathoe HM et al. Hypertensive target organ damage and the risk for vascular events and all-cause mortality in patients with vascular disease [J]. J Hypertens, 2013, 31(3): 492-500.
  • 8Shl0mai G, Grassi G, Grossman E, et al. Assessment of Target Organ Damage in the Evaluation and Follow-Up of Hypertensive Patientst Where Do We Stand [J]. J Clin Hypertens (Greenwich), 2013, 15(10): 742-747.
  • 9Lindholm LH, Ibsen H, Dahl6f B, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpolnt Reduction in hypertension study ( LIFE ). a randomized trial against atenolol [J]. Lancet, 2002, 359 (9311) : 1004-1010.
  • 10Taylor J. 2013 ESH/ESC guidelines for the management of arterial hypertension[J]. Eur Heart J, 2013, 34 (28) : 2159- 2219.

二级参考文献70

共引文献120

同被引文献28

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部